By Frances Stocks Allen, Hector Armengod, Christoph Engeler and Robbie McLaren (January 15, 2019, 2:04 PM EST) -- There are now fewer than three months to go until the United Kingdom's exit from the European Union on March 29, 2019. On Jan. 15, 2019, the U.K. government rejected the provisional deal proposed by the prime minister and accepted by the EU which would have offered terms for Brexit and future interactions between the U.K. and the EU following the withdrawal date. Unless the EU and the U.K. agree to an alternative deal, the withdrawal date is delayed or Article 50 is revoked, all EU primary and secondary law will cease to apply to the U.K. with effect from the withdrawal date, and the U.K. will become a "third country" for the purposes of EU legislation. Under this no-deal Brexit scenario, all provisions of EU law relating to EU member states will no longer apply to the U.K., with potentially chaotic results for the life sciences industry....